Skip to main content

Table 2 RAD21 expression in DCIS subtypes (P = 0.471)

From: Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers

Subtype

Negative

n (%)

Positive

n (%)

Total

n (%)

Luminal

21 (55.3%)

17 (44.7%)

38 (100%)

Basal

0 (.0%)

1 (100.0%)

1 (100%)

HER2

7 (43.8%)

9 (56.2%)

16 (100%)

Null

3 (75.0%)

1 (25.0%)

4 (100%)

Total

31 (52.5%)

28 (47.5%)

59 (100.0%)

  1. DCIS, ductal carcinoma in situ.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us